Antiviral and virucidal activities of natural products

Current Medicinal Chemistry

Volumn 16, Issue 20, 2009, Pages 2485-2497

  Arakawa, Tsutomu ^a,b   Yamasaki, Hisashi ^b   Ikeda, Keiko ^b   Ejima, Daisuke ^c   Naoto, Takeshi ^d   Koyama, A Hajime ^b  

^a ALLIANCE PROTEIN LABORATORIES   (United States)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^c AJINOMOTO CO INC   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antiviral reagent; Arginine; Ascorbic acid; Coffee; Gallate; Virus inactivation

Indexed keywords

ARGININE; ASCORBIC ACID; CAFFEIC ACID; CAFFEINE; CITRIC ACID; COFFEE EXTRACT; DEHYDROASCORBIC ACID; EPIGALLOCATECHIN GALLATE; GALLIC ACID DERIVATIVE; GALLIC ACID OCTYL ESTER; NATURAL PRODUCT; PRODELPHINIDIN B 2 3' O GALLATE; SCOPARIC ACID B; SCOPARIC ACID C; UNCLASSIFIED DRUG;

ANTIHERPETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CELL DEATH; CELL STRAIN; CLINICAL TRIAL; COFFEE; CYTOPATHOGENIC EFFECT; DNA REPLICATION; DOSE RESPONSE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SENSITIVITY; DRUG STRUCTURE; HEP 2 CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HYDROPHOBICITY; IMMUNOMODULATION; INFLUENZA VIRUS; MOUTH INFECTION; NONHUMAN; PH; PHASE TRANSITION; POLIOMYELITIS VIRUS; REVIEW; TEMPERATURE; VIROGENESIS; VIRUCIDAL ACTIVITY; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; VERO CELLS; VIRUSES;

EID: 70349392535     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788682065     Document Type: Review

References (85)

1. Evengard, B.; Ehrnst, A.; von Sydow, M.; Pehrson, P.O.; Lundbergh, P.; Linder, E. Effect of heat on extracted HIV viral infectivity and antibody activity using the filter paper technology of blood sampling. AIDS, 1989, 3, 591-5.
2. Nowak, T.; Gregersen, J.P.; Klockmann, U.; Cummins, L.B.; Hilfenhaus, J. Virus safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure. J. Med. Virol., 1992, 36, 209-16.
3. Smales, C.M.; Pepper, D.S.: James, D.C. Protein modification during antiviral heat processing. Biotechnol. Bioeng., 2000, 67, 177-88.
4. Swayne, D.E.; Beck, J.R. Heat inactivation of avian influenza and Newcastle disease viruses in egg products. Avian Pathol., 2004, 33, 512-8.
5. Tomasula, P.M.; Kozempel, M.F.; Konstance, R.P.; Gregg, D.; Boettcher, S.; Baxt, B.; Rodriguez, L.L. Thermal inactivation of foot-and-mouth disease virus in milk using high-temperature, shorttime pasteurization. J. Dairy Sci., 2007, 90, 3202-11.
6. Graham, D.A.; Staples, C.; Wilson, C.J.; Jewhurst, H.; Cherry, K.; Gordon, A.; Rowley, H.M. Biophysical properties of salmonid alphaviruses: Influence of temperature and pH on virus survival. J. Fish Dis., 2007, 30, 533-43.
7. Preuss, T.; Kamstrup, S.; Kyvsgaard, N.C.; Nansen, P.; Miller, A.; Lei, J.C. Comparison of two different methods for inactivation of viruses in serum. Clin. Diagn. Lab. Immunol., 1997, 4, 504-8
8. Brorson, K.; Krejci, S.; Lee, K.; Hamilton, E.; Stein, K.; Xu, Y. Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins. Biotechnol. Bioeng., 2003, 82, 321-9.
9. Brorson, K.; Norling, L; Hamilton, E.; Lute, S.; Lee, K.; Curtis, S.; Xu, Y. Current and future approaches to ensure the viral safety of biopharmaceuticals. Dev. Biol (Basel)., 2004, 118, 17-29.
10. Evengard, B.; von Sydow, M.; Ehrnst, A.; Pehrson, P.O.; Lundbergh, P.; Linder, E. Filter paper sampling of blood infected with HIV: Effect of heat on antibody activity and viral infectivity. BMJ., 1988, 297, 1178.
11. Roberts, P. Virus safety of plasma products. Rev. Med. Virol., 1996, 6, 25-38.
12. Roberts, P.L.; Lloyd, D. Virus inactivation by protein denaturants used in affinity chromatography. Biologicals, 2007, 35, 343-7.
13. Bonn, D. Green coffee beans may yield new class of anti-HIV-1 agents. Lancet, 1998, 352, 1039.
14. Kobayashi, N.; Unten, S.; Kakuta, H.; Komatsu, N.; Fujimaki, M.; Satoh, K.; Aratsu, C.; Nakashima, H.; Kikuchi, H.; Ochiai, K.; Sakagami, H. Diverse biological activities of healthy foods. In Vivo, 2001, 15, 17-23.
15. Namba, T.; Kurokawa, M.; Kadota, S.; Shiraki, K. Development of antiviral therapeutic agents from traditional medicines. Yakugaku Zasshi, 1998, 118, 383-400.
16. Utsunomiya, M.; Ichinose, M.; Uozaki, M.; Tsujimoto, K.; Yamasaki, H.; Koyama, A.H. Antiviral activities of coffee extracts in vitro. Food Chem. Toxicol., 2008, 46, 1919-24.
17. Dorea, J.G.; da Costa, T.H. Is coffee a functional food? Br. J. Nutr., 2005, 93, 773-82.
18. Ranheim, T.; Halvorsen, B. Coffee consumption and human health-beneficial or detrimental? - Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease abd type 2 diabetes mellitus. Mol. Nutr. Food Res., 2005, 49, 274-84.
19. Xu, J.; Wang, J.; Deng, F.; Hu, Z.; Wang, H. Green tea extract and its major component epigallocatechin gallate inhibit hepatitis B virus in vitro. Antiviral Res., 2008, 78, 242-9.
20. Ahn, Y.J.; Lee, C.O.; Kweon, J.H.; Ahn, J.W.; Park, J.H. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. J. Appl. Microbiol., 1998, 84, 439-43
21. Uozaki, M.; Yamasaki, H.; Katsuyama, Y.; Higuchi, M.; Higuti, T.; Koyama, A.H. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res., 2007, 73, 85-91.
22. Ow, Y-Y.; Stupans, I. Gallic acid and gallic acid derivatives: Effects on drug metabolizing enzymes. Curr. Drug Metab., 2003, 4, 241-8.
23. van der Heijden, C.A.; Janssen, P.J.; Strik, J.J. Toxicology of gallates: A review and evaluation. Food Chem. Toxicol., 1986, 24, 1067-70.
24. Bub, A.; Watzl, B.; Blockhaus, M.; Briviba, K.; Liegibel, U.; Muller, H.; Pool-Zobel., B.L.; Rechkemmer, G. Fruit juice consumption modulates zntioxidative status, immune status and DNA damage. J. Nutr. Biochem., 2003, 14, 90-8.
25. Chung, K.T.; Wong, T.Y.; Wei, C.I.; Huang, Y.W.; Lin, Y. Tannins and human health. Crit. Rev. Food Sci. Nutr., 1998, 38, 421-64.
26. Isaacs, C.E.; Wen, G.Y.; Xu, W.; Jia, J.H.; Rohan, L.; Corbo, C.; Di Maggio, V.; Jenkins, E.C. Jr.; Hillier, S. Epigallocatechin gallate inactivates clinical isolates of herper simplex virus. Antimicrob. Agents Chemother., 2008, 52, 962-70.
27. Cowan. M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev., 1999, 12, 564-82.
28. Katula, K.S.; McCain, J.A.; Radewicz, A.T. Relative ability of dietary compounds to modulate nuclear factor-kappaB activity as assessed in a cell-based reporter system. J. Med. Food, 2005, 8, 269-74.
29. Hayashi, T. Studies on evaluation of natural products for antiviral effects and their applications. Yakugaku Zasshi, 2008, 128, 61-79
30. Steele, R.W.; Charlton, R.K Immune modulators as antiviral agents. Clin. Lab Med., 1987, 7, 911-24.
31. Harakeh, S.; Jariwalla, R.J. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am. J. Clin. Nutr., 1991, 54, 1231S-5S.
32. Jariwalla, R.J.; Harakeh, S. Antiviral and immunomodulatory activities of ascorbic acid. Subcell Biochem., 1996, 25, 213-31.
33. Furuya, A.; Uozaki, M.; Yamasaki, H.; Arakawa, T.; Koyama, A.H. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int. J. Mol. Med., 2008, 22, 541-5.
34. Takada, H.; Kishimoto, C.; Hiraoka, Y.; Ochiai, H. Oral L-arginine prevents murine coxsackievirus B3 myocarditis. Int. J. Cardiol., 2002, 86, 273-9.
35. Agawa, H.; Ikuta, K.; Minamiyama, Y.; Inoue, M.; Sairenji, T. Down regulation of spontaneous Epstein-Barr reactivation in the P3HR-1 cell line by L-arginine. Virology, 2002, 304, 114-24
36. Wu, J.J.; Pang, K.R.; Huang, D.B.; Tyring, S.K. Advances in antiviral therapy. Dermatol. Clin., 2005, 23, 313-22.
37. Yamasaki, H.; Tsujimoto, K.; Koyama, A.H.; Ejima, D.; Arakawa, T. Arginine facilitates inactivation of enveloped viruses. J. Pharm. Sci., 2008, 97, 3067-73.
38. Katsuyama, Y.; Yamasaki, H.; Tsujimoto, K.; Koyama, A.H.; Ejima, D.; Arakawa, T. Butyroyl-arginine as a potent virus inactivation agent. Int. J. Pharm., 2008, 361, 92-8.
39. Utsunomiya, H.; Ichinose, M.; Tsujimoto, K.; Katsuyama, Y.; Yamasaki, H.; Koyama, A.H.; Ejima, D.; Arakawa, T. Cooperative thermal inactivation of herpes simplex virus and influenza virus by arginine and NaCl. Int. J. Pharm., 2009, 366, 99-102.
40. Arakawa, T.; Kita, Y.; Koyama, A.H. Synergistic virus inactivation effects of arginine. Biotechnol. J., 2009, 4, 174-8.
41. Naito, T.; Irie, H.; Tsujimoto, K.; Ikeda, K.; Arakawa, T.; Koyama, A.H. Antiviral effects of arginine against herpes simplex virus type 1. Int. J. Mol. Med., 2009, 23, 495-9.
42. Shibata, H.; Kondo, K.; Katsuyama, R.; Kawazoe, K.; Sato, Y.; Murakami, K.; Takaishi, Y.; Arakaki, N.; Higuti, T. Alkyl gallates, intensifiers of beta-lactam susceptibility in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 2005, 49, 549-55.
43. Cheng, H.Y.; Lin, T.C.; Ishimaru, K.; Yang, C.M.; Wang, K.C.; Lin, C.C. In vitro antiviral activity of prodelphinidin B-2 3.3'-di-Ogallate from Myrica rubra. Planta Med., 2003, 69, 953-6.
44. Cheng, H.Y.; Lin, C.C.; Lin, T.C. Antiviral properties of prodelphinidin B-2 3′-O-gallate from green tea leaf. Antivir. Chem. Chemother., 2002, 13, 223-9.
45. Lin, L.C.; Kuo, Y.C.; Chou, C.J. Anti-herpes simplex virus type-1 flavonoids and a new flavanone from the root of Limonium sinense. Planta Med., 2000, 66, 333-6.
46. Mukoyama, A.; Ushijima, H.; Nishimura, S. Koike, H.; Toda, M.; Hara, Y.; Shimamura, T. Inhibition of rotavirus and enterovirus by tea extracts Jpn. J. Med. Sci. Biol., 1991, 44, 181-6.
47. Nakayama, M.; Suzuki, K.; Toda, M.; Okubo, S.; Hara, Y.; Shimamura, T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral. Res., 1993, 21, 289-99.
48. Song, J.M.; Lee, K.H.; Seong, B.L Antiviral effect of catechins in green tea on influenza virus. Antiviral. Res., 2005, 68, 55-74.
49. Weber, J.M.; Ruzindana-Umunyana, A.; Imbeault, L.; Sircar, S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral. Res., 2003, 58, 167-73.
50. Kane, C.J.; Menna, J.H.; Yeh, Y.C. Methy gallate, methyl-3,4,5-trihydroxybenzoate, is a potent and highly specific inhibitor of herpes simplex virus in vitro. I. Purification and characterization of methyl gallate from Sapium sebiferum. Biosci. Rep., 1988, 8, 85-94.
51. Kane, C.J.: Menna, J.H.: Sung, C.C.: Yeh, Y.C. Methy gallate, methyl-3,4,5-trihydroxybenzoate, is a potent and highly specific inhibitor of herpes simplex virus in vitro. II. Antiviral activity of methyl gallate and its derivatives. Biosci. Rep., 1988, 8, 95-102.
52. Savi, LA.: Leal, P.C.; Vieira, T.O.; Rosso, R.; Nunes, R.J.; Yunes, R.A.; Creczynski-Pasa, T.B.; Barardi, C.R.; Simoes, C.M. Evaluation of anti-herpetic and antioxidant activities, and cytotoxic and genotoxic effects of synthetic alkyl-esters of gallic acid. Arzneimittelforschung, 2005, 55, 66-75.
53. Shiraki, K.; Rapp, F. Effects of caffeine on herpes simplex virus. Intervirology, 1988, 29, 235-40.
54. Yamazaki, Z.; Tagaya, I. Antiviral effects of atropine and caffeine. J. Gen. Virol., 1980, 50, 429-31.
55. Racaniello, V.R.; Ren, R. Poliovirus biology and pathogenesis. Curr. Top Microbiol. Immunol., 1996, 206, 305-25.
56. Roizman, B.; Knipe, D.M. Herpes simplex virus and their replication. In: Fields Virology. 4th edition. Fields, B.N., Knipe, D.M. and Howley, P.M. (eds.). Lippincott-Raven, New York, pp1487-1530, 2001.
57. Zavate, O.; Tiron, S.; Cotor, F. Preliminary data on the survival length of enteroviruses in nanoalcoholic beverages. In activation action of some medicinal herb infusions. Virologie, 1982, 33, 231-6.
58. Standard Tables of Food Composition in Japan, Fifth revised and enlarged edition by the Ministry of Education, Culture, Sports, Science and Technology, Japan, 2005.
59. Murayama, M.; Tsujimoto, K.; Uozaki, M.; Katsuyama, Y.; Yamasaki, H.; Utsunomiya, H.; Koyama, A.H. Effect of caffeine on the multiplication of DNA and RNA viruses. Mol. Med. Reports, 2008, 1, 251-5.
60. Jiang, R.W.; Lau, K.M.; Hon, P.M.; Mak, T.C.; Woo, K.S.; Fung, K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem., 2005, 12, 237-46.
61. Pauling, L. Are recommended daily allowances for vitamin C adequate? Proc. Natl. Acad. Sci. USA., 1974, 71, 4442-6.
62. Cameron, E. Vitamin C and cancer: An overview. Int. J. Vitam. Nutr. Res. Suppl., 1982, 23, 115-27.
63. Hamuy, R.; Berman, B. Treatment of herpes simplex virus infections with topical antiviral agents. Eur. J. Dermatol., 1998, 8, 310-9.
64. Mossad, S.B. Current and future therapeutic approaches to the common cold. Expert Rev. Anti. Infect. Ther., 2003, 1, 619-26.
65. Kolb, H.; Kolb-Bachofen, V. Nitric oxide: A pathogenetic factor in autoimmunity. Immunol. Today, 1992, 13, 157-60
66. Appleton, J. Arginine: Clinical potential of a semi-essebtialamino. Altern. Med. Rev., 2002, 7, 512-22.
67. Evoy, D.; Lieberman, M.D.; Fahey, T.J.3rd.; Daly, J..M. Immunomodulation: The role of arginine. Nutrition, 1998, 14, 611-7.
68. Efron, D.T.; Barbul, A. Arginine and nutrition in renal disease. J. Ren. Nutr., 1999, 9, 142-4.
69. Schneider, H.; Atkinson, S.W. Immunonutrition - fact or fad. J. Nutr. Health Aging, 2000, 4, 120-3.
70. Cynober, L. Can arginine and ornithine support gut functions? Gut, 1994, 35, S42-5.
71. Alexander, J.W.; Peck, M.D. Future prospects for adjunctive therapy: pharmacologic and nutritional approaches to immune system modulation. Crit. Care Med., 1990, 18, S159-64.
72. Boot, H.J.; Kasteel, D.T.; Buisman, A.M.; Kimman, T.G. Extraction of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice. J. Virol., 2003, 77, 6541-5.
73. Hsu, F.L.; Chang, H.T.; Chang, S.T. Evaluation of antifungal properties of octyl gallate and its synergy with cinnamaldehyde. Bioresour. Technol., 2007, 98, 734-8.
74. Koyama, A.H.; Arakawa, T.; Adachi, A. Acceleration of virus-induced apoptosis by tumor necrosis factor. FEBS Lett., 1998, 426, 179-82.
75. Koyama, A.H.; Fukumori, T.; Fujita, M.; Irie, H.; Adachi, A. Physiological significance of apoptosis in animal virus infection. Microbes Infect., 2000, 2, 1111-7.
76. Hayashi, T.; Kishi, M.; Kawasaki, M.; Arisawa, M.; Shimizu, M.; Suzuki, S.; Yoshizaki, M.; Morita, N.; Tezuka, Y.; Kikuchi, T.; Berganza, L.H.; Ferro, E.; Basualdo, I. Scopadulcic acid-A and -B, new diterpenoids with a novel skeleton, from a Paraguayan crude "Typycha karutu" (Scoparia Dulcis L.). Tetrahedron Lett., 1987, 28, 3693-6.
77. Hayashi, T.; Kawasaki, M.; Miwa, Y.; Taga, T.; Morita, N. Antiviral agents of plant origin. III. Scopadulin, a novel tetracyclic diterpene from Scoparia dulcis L. Chem. Pharm. Bull., 1990, 38, 945-7
78. Hayashi, K.; Hayashi, T. Scopadulciol is an inhibitor of herpes simplex virus type 1 and a potentiator of aciclovir. Antiviral Chem. Chemother., 1996, 7, 79-85.
79. Koyama, A.H.; Uchida, T. Quantitative studies on the maturation process of herpes simplex virus type 1 in Vero cells. Virus Res., 1988, 10, 281-5.
80. Buchacher, A.; Iberer, G, Purification of intravenous immunoglobulin G from human plasma-aspects of yield and varus safety. Biotechnol. J., 2006, 1, 148-63.
81. Farshid, M.; Taffs, R.E.; Scott, D.; Asher, D.M.; Brorson, K. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. Curr. Opin. Biotechnol., 2005, 16, 561-7.
82. Shi, L.; Chen, Q.; Norling, L.A.; Lau, A.S.; Xu, Y. Biotechnol. Bioeng., 2004, 87, 884-896.
83. Calnan, B.J.; Tidor, B.; Biancalana, S.; Hudson, D.; Frankel, A.D. Science, 1991, 252, 1167-1171.
84. Hirai, A.: Kawasaki, H.: Tanaka, S.: Nemoto, N.: Suzuki, M.; Maeda, H. Colloid Polymer Sci., 2005, 284, 520-528.
85. Arakawa, T.; Tsumoto, K. The effects of arginine on refolding of aggregated proteins: Not facilitate refolding, but suppress aggregation. Biochem. Biophys. Res. Commun. 2003, 304, 148-152